프로그램
| Time | Title | Chairperson/Speaker |
|---|---|---|
| 08:55-09:00 | Registration | |
| 09:00-09:05 | Opening Remarks | Yun Sil Chang (Director of Cell and Gene Therapy Institute, Samsung Medical Center, Korea) |
| 09:05-09:10 | Welcome Address | Kyu-Sung Lee (Director, Research Institute for Future Medicine, Samsung Medical Center, Korea) |
| 09:10-09:15 | Congratulatory Address | Seung Woo park (President of Samsung Medical Center, Korea) |
| Session I. Translational & Clinical Research of Cell · Gene therapy for Incurable Diseases | Chair : Il-Hoan Oh (The Catholic University of Korea, Korea) Yun Sil Chang ( Director of Cell and Gene Therapy Institute, Korea) |
|
| 09:15-09:30 | Introduction of Cell and Gene therapy institute | Yun Sil Chang (Director of Cell and Gene Therapy Institute, Samsung Medical Center, Korea) |
| 09:30-09:35 | Discussion | |
| 09:35-10:05 | Next Steps for CAR T-cell Therapy in Lymphoma | Sattva S Neelapu (The University of Texas MD Anderson Cancer Center, USA) |
| 10:05-10:10 | Discussion | |
| 10:10-10:40 | Piloting pathways for “interventional genomics” in orphan neurologic disease. | Timothy Yu (Harvard Medical School, USA) |
| 10:40-10:45 | Discussion | |
| 10:45-11:00 | Retinal gene therapy – Current status and future perspective | Sang Jin Kim (Samsung Medical Center, Korea) |
| 11:00-11:05 | Discussion | |
| Session II. Advanced disease modeling using Regenerative Medicine Technology | Chair : Inho Jo (Korean Fund for Regenerative Medicine, Korea) Jihwan Song (CHA University, Korea) |
|
| 11:05-11:25 | Generation of the human brain organoids to investigate human development and diseases | In-Hyun Park (Yale University School of Medicine, USA) |
| 11:25-11:45 | Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment | Gabsang Lee (Johns Hopkins University School of Medicine, USA) |
| 11:45-12:05 | Development of biohybrid muscular platforms for regenerative medicine | Sung Jin Park (Georgia Institute of Technology & Emory University School of Medicine, USA) |
| 12:05-12:25 | Engineering nano-biomaterials for tissue fabrication and regenerative medicine | Su Ryon Shin (Harvard Medical School, USA) |
| 12:25-12:45 | Discussion | |
| 12:45-13:35 | Lunch | |
| Session III. Perspective: Advanced Technology of Gene Therapy to Clinical Progress | Chair: Tae Kwann Park (Soonchunhyang University Hospital Bucheon, Korea) Jeehun Lee (Samsung Medical Center, Korea) |
|
| 13:35-13:50 | Regeneration of articular cartilage, suppression of synovial inflammation, and alleviation of joint pain after intra-articular injection of ICM-203 in canine OA model | Dae-Won Kim (Yonsei University, ICM Co. Ltd.,(CEO), Korea) |
| 13:50-14:05 | Brain somatic mutations as RNA therapeutic targets in neurological disorders | Jeong Ho Lee (Korea Advanced Institute of Science and Technology (KAIST), Sovargen Co. LTD., Korea) |
| 14:05-14:15 | Discussion | |
| 14:15-14:30 | Break | |
| Session IV. Perspective: Clinical application of Gene-modified cell therapy | Chair : Heechung Kwon (KIRAMS; President, KSGCT; CEO, Gencellmed Inc., Korea) Keon Hee Yoo (Samsung Medical Center, Korea) |
|
| 14:30-14:45 | A method to enhance the safety of Stem Cell-Based Ex-Vivo Therapy | Haeyoung Suh-Kim (Ajou University School of Medicine, CELLeBRAIN(CEO), Korea) |
| 14:45-15:00 | CAR T-cell therapy in Samsung Medical Center | Seok Jin Kim (Samsung Medical Center, Korea) |
| 15:00-15:15 | Next Generation CAR-T cell therapy against hematological malignancies | Kyungho Choi (Seoul National University College of Medicine, Korea) |
| 14:05-14:15 | Discussion | |
| Session V. Recent Advances and Future Perspectives-Organoids | Chair : Hyung-Ryong Kim (Jeonbuk National University, The President of The Organoid Society, Korea) Jae Ho Kim (Pusan National University School of Medicine, Korea) |
|
| 15:30-15:45 | p57Kip2 imposes the reserve stem cell state of gastric chief cells | Bon-Kyoung Koo (Center for genome engineering, Institute for Basic Science, Korea) |
| 15:45-16:00 | Massive Expansion of hiPSC-derived Cardiomyocytes for Personalized Cardiac Tissue Engineering | Soah Lee (Biopharmaceutical Convergence, School of Pharmacy, Sungkyunkwan University, Korea) |
| 16:00-16:10 | Discussion | |
| Session VI. Recent Advances and Future Perspectives-Exosome | Chair : Yong Song Gho (POSTECH, Korea) Oh Young Bang (Samsung Medical Center, Korea) |
|
| 16:10-16:25 | Clinical applications of EV DNA for liquid biopsy in lung adenocarcinoma | Kye Young Lee (Precision Medicine Lung Cancer Center, Konkuk University Medical Center, Korea) |
| 16:25-16:40 | Exosome engineering for active targeting and intracellular delivery of therapeutic proteins: realization from concept | Chulhee Choi (ILIAS Biologics Inc., KAIST, Korea) |
| 16:40-16:55 | Efficient production of stem cell-derived extracellular vesicles with high therapeutic efficacy for the treatment of intractable diseases | Ssang-Goo Cho (Konkuk University & StemEXOne Inc., Korea) |
| 16:55-17:10 | Discussion | |
| 17:10 ~ | Adjourn | |